See All Slides - tctmd.com

Slides

Presentation TCT 2012

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

BioFreedom (Biosensors International) Program Update

Presenter: Philip Urban

October 23, 2012

Presentation TCT 2012

2-D TEE, 3-D TEE, and Fluoro-Echo Overlay: What Is Essential and What Is Nice to Have?

Presenter: Ilona Hofmann

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

Presenter: David Morrow

October 23, 2012

Presentation TCT 2012

The HDL Hypothesis: A Critical Reappraisal

Presenter: Robert Wilensky

October 23, 2012

Presentation TCT 2012

ELM Presentation(5)

Presenter: Navin Kapur

October 23, 2012

Presentation TCT 2012

Case Example: How Severe Is the MR in this Patient?

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

Vessel Rupture and Perforation: Frequency, Locations and Management

Presenter: Zvonimir Krajcer

October 23, 2012

Advertisement

Slides

Chronic Kidney Disease, Contrast Agents, and Radiocontrast Nephropathy

Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results

BioFreedom (Biosensors International) Program Update

2-D TEE, 3-D TEE, and Fluoro-Echo Overlay: What Is Essential and What Is Nice to Have?

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

The HDL Hypothesis: A Critical Reappraisal

ELM Presentation(5)

Case Example: How Severe Is the MR in this Patient?

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Vessel Rupture and Perforation: Frequency, Locations and Management

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content